Systemic sclerosis is a generalized disorder of connective tissue in which the pattern of disease extent progression and outcome is heterogenous. To determine clinical features, disease extent and progression, we studied our patients in two phases of disease; early (the first 3 years) and late phases (after 6 years of disease). 19 patients had diffuse cutaneous and 34 patients had limited cutaneous scleroderma. In patients with diffuse cutaneous scelroderma, disease progression has occured mostly in the early phase of disease, but inpatients wit limited cutaneous scleroderma, disease progression was slow and incidious, so diseise progression has occured mostly in the late phase of the disease thus raymiud"s phenomenon, telangiectasia, hyperpigmentation. and esophagitis were observed more in the late phase of the disease (statistically significant). In comparison of two groups, dearly and extensive organ involvement was observed in patients with diffuse cutaneous scleroderma.